Skip to main content
Top
Published in: BMC Pediatrics 1/2024

Open Access 01-12-2024 | Nifedipine | Research

Efficient administration of a combination of nifedipine and sildenafil citrate versus only nifedipine on clinical outcomes in women with threatened preterm labor: a systematic review and meta-analysis

Authors: Elham Manouchehri, Somayeh Makvandi, Mahdieh Razi, Maryam Sahebari, Mona Larki

Published in: BMC Pediatrics | Issue 1/2024

Login to get access

Abstract

Background

Preterm labor (PTL) is a common and serious pregnancy disorder that can cause long-term neurological issues in the infant. There are conflicting studies concerning whether sildenafil citrate (SC) reduces preterm labor complications. Therefore, the meta-analysis aimed to examine the clinical outcomes in women with threatened PTL who received nifedipine plus SC therapy versus only nifedipine.

Methods

For the original articles, six databases were searched using relevant keywords without restriction on time or language until January 13, 2024. The Cochrane risk-of-bias tool for randomized trials (RoB) and the Risk of Bias Assessment Tool for Nonrandomized Studies (RoBANS) were both used to assess the risk of bias in randomized and non-randomized studies, and GRADE determined the quality of our evidence. Meta-analysis of all data was carried out using Review Manager (RevMan) version 5.1.

Results

Seven studies with mixed quality were included in the meta-analysis. The study found that combining nifedipine and SC resulted in more prolongation of pregnancy (MD = 6.99, 95% CI: 5.32, 8.65, p < 0.00001), a lower rate of delivery in the 1st to 3rd days after hospitalization (RR = 0.62, 95% CI: 0.50, 0.76, p < 0.00001), a higher birth weight (252.48 g vs. nifedipine alone, p = 0.02), and the risk ratio of admission to the neonatal intensive care unit (NICU) was significantly lower (RR = 0.62, 95% CI: 0.50, 0.76, p < 0.00001) compared to nifidepine alone. The evidence was high for prolongation of pregnancy, delivery rate 24–72 h after admission, and NICU admission, but low for newborn birth weight.

Conclusions

Given the effectiveness of SC plus nifedipine in increased prolongation of pregnancy and birth weight, lower delivery in the 1st to 3rd days after hospitalization, and NICU admission, Gynecologists and obstetricians are suggested to consider this strategy for PTL management, although additional article rigor is required to improve the quality of the evidence.
Literature
1.
go back to reference Ohuma EO, Moller A-B, Bradley E, Chakwera S, Hussain-Alkhateeb L, Lewin A, et al. National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis. Lancet. 2023;402(10409):1261–71.CrossRefPubMed Ohuma EO, Moller A-B, Bradley E, Chakwera S, Hussain-Alkhateeb L, Lewin A, et al. National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis. Lancet. 2023;402(10409):1261–71.CrossRefPubMed
2.
go back to reference Giouleka S, Tsakiridis I, Kostakis N, Koutsouki G, Kalogiannidis I, Mamopoulos A, et al. Preterm labor: a comprehensive review of guidelines on diagnosis, management, prediction and prevention. Obstet Gynecol Surv. 2022;77(5):302–17.CrossRefPubMed Giouleka S, Tsakiridis I, Kostakis N, Koutsouki G, Kalogiannidis I, Mamopoulos A, et al. Preterm labor: a comprehensive review of guidelines on diagnosis, management, prediction and prevention. Obstet Gynecol Surv. 2022;77(5):302–17.CrossRefPubMed
3.
go back to reference Boobpamala S, Jindapaisan S, Wanniyom N, Thessawadwong R. Effectiveness of the Preterm Labor Prevention Program for High-Risk Pregnant Women: A Randomized Controlled Trial. Pacific Rim Intl Journal of Nursing Research. 2024;28(1):71–87.CrossRef Boobpamala S, Jindapaisan S, Wanniyom N, Thessawadwong R. Effectiveness of the Preterm Labor Prevention Program for High-Risk Pregnant Women: A Randomized Controlled Trial. Pacific Rim Intl Journal of Nursing Research. 2024;28(1):71–87.CrossRef
4.
go back to reference Harrison MS, Goldenberg RL. Global burden of prematurity. Semin Fetal Neonatal Med. 2016;21(2):74–9. Harrison MS, Goldenberg RL. Global burden of prematurity. Semin Fetal Neonatal Med. 2016;21(2):74–9.
5.
go back to reference Catov JM, Scifres CM, Caritis SN, Bertolet M, Larkin J, Parks WT. Neonatal outcomes following preterm birth classified according to placental features. Am J Obstet Gynecol. 2017;216(4):411. e1-.e14.CrossRefPubMed Catov JM, Scifres CM, Caritis SN, Bertolet M, Larkin J, Parks WT. Neonatal outcomes following preterm birth classified according to placental features. Am J Obstet Gynecol. 2017;216(4):411. e1-.e14.CrossRefPubMed
6.
go back to reference Abdulhameed WA, Abbood MS, Jwad MA. Comparison between the effect of sildenafil citrate and routine tocolytic agents in a prevention of preterm labor. NVEO NAT VOLATILES ESSENTIAL OILS J . 2021:4590–602. Abdulhameed WA, Abbood MS, Jwad MA. Comparison between the effect of sildenafil citrate and routine tocolytic agents in a prevention of preterm labor. NVEO NAT VOLATILES ESSENTIAL OILS J . 2021:4590–602.
7.
go back to reference Organization WH. WHO recommendations on antenatal corticosteroids for improving preterm birth outcomes. In: WHO recommendations on antenatal corticosteroids for improving preterm birth outcomes. 2022. p. 40. Organization WH. WHO recommendations on antenatal corticosteroids for improving preterm birth outcomes. In: WHO recommendations on antenatal corticosteroids for improving preterm birth outcomes. 2022. p. 40.
8.
go back to reference Vogel JP, Ramson J, Darmstadt GL, Qureshi ZP, Chou D, Bahl R, Oladapo OT. Updated WHO recommendations on antenatal corticosteroids and tocolytic therapy for improving preterm birth outcomes. Lancet Glob Health. 2022;10(12):e1707–8.CrossRefPubMedPubMedCentral Vogel JP, Ramson J, Darmstadt GL, Qureshi ZP, Chou D, Bahl R, Oladapo OT. Updated WHO recommendations on antenatal corticosteroids and tocolytic therapy for improving preterm birth outcomes. Lancet Glob Health. 2022;10(12):e1707–8.CrossRefPubMedPubMedCentral
9.
go back to reference Khan RN, Hamoud H, Warren A, Wong LF, Arulkumaran S. Relaxant action of sildenafil citrate (Viagra) on human myometrium of pregnancy. Am J Obstet Gynecol. 2004;191(1):315–21.CrossRefPubMed Khan RN, Hamoud H, Warren A, Wong LF, Arulkumaran S. Relaxant action of sildenafil citrate (Viagra) on human myometrium of pregnancy. Am J Obstet Gynecol. 2004;191(1):315–21.CrossRefPubMed
10.
go back to reference Reynolds LP, Caton JS, Redmer DA, Grazul-Bilska AT, Vonnahme KA, Borowicz PP, et al. Evidence for altered placental blood flow and vascularity in compromised pregnancies. J Physiol. 2006;572(1):51–8.CrossRefPubMedPubMedCentral Reynolds LP, Caton JS, Redmer DA, Grazul-Bilska AT, Vonnahme KA, Borowicz PP, et al. Evidence for altered placental blood flow and vascularity in compromised pregnancies. J Physiol. 2006;572(1):51–8.CrossRefPubMedPubMedCentral
11.
go back to reference Sun X, Wang K, Wang W, Li B. Clinical study on sildenafil in treatment of pregnant women with pulmonary arterial hypertension. Zhonghua Fu Chan Ke Za Zhi. 2014;49(6):414–8.PubMed Sun X, Wang K, Wang W, Li B. Clinical study on sildenafil in treatment of pregnant women with pulmonary arterial hypertension. Zhonghua Fu Chan Ke Za Zhi. 2014;49(6):414–8.PubMed
12.
go back to reference Brownfoot FC, Tong S, Hannan NJ, Cannon P, Nguyen V, Tu’uhevaha J. Effect of sildenafil citrate on circulating levels of sFlt-1 in preeclampsia. Pregn Hypertens. 2018;13:1–6.CrossRef Brownfoot FC, Tong S, Hannan NJ, Cannon P, Nguyen V, Tu’uhevaha J. Effect of sildenafil citrate on circulating levels of sFlt-1 in preeclampsia. Pregn Hypertens. 2018;13:1–6.CrossRef
13.
go back to reference Trapani A Jr, Gonçalves LF, Trapani TF, Vieira S, Pires M, de Souza Pires MM. Perinatal and hemodynamic evaluation of sildenafil citrate for preeclampsia treatment: a randomized controlled trial. Obstet Gynecol. 2016;128(2):253–9.CrossRefPubMed Trapani A Jr, Gonçalves LF, Trapani TF, Vieira S, Pires M, de Souza Pires MM. Perinatal and hemodynamic evaluation of sildenafil citrate for preeclampsia treatment: a randomized controlled trial. Obstet Gynecol. 2016;128(2):253–9.CrossRefPubMed
14.
go back to reference Shehata NA, Ali HA, Fahim AS, Katta MA, Hussein GK. Addition of sildenafil citrate for treatment of severe intrauterine growth restriction: a double blind randomized placebo controlled trial. J Matern Fetal Neonatal Med. 2020;33(10):1631–7.CrossRefPubMed Shehata NA, Ali HA, Fahim AS, Katta MA, Hussein GK. Addition of sildenafil citrate for treatment of severe intrauterine growth restriction: a double blind randomized placebo controlled trial. J Matern Fetal Neonatal Med. 2020;33(10):1631–7.CrossRefPubMed
15.
go back to reference Trapani A Jr, Gonçalves L, Trapani T, Franco M, Galluzzo R, Pires M. Comparison between transdermal nitroglycerin and sildenafil citrate in intrauterine growth restriction: effects on uterine, umbilical and fetal middle cerebral artery pulsatility indices. Ultrasound Obstet Gynecol. 2016;48(1):61–5.CrossRefPubMed Trapani A Jr, Gonçalves L, Trapani T, Franco M, Galluzzo R, Pires M. Comparison between transdermal nitroglycerin and sildenafil citrate in intrauterine growth restriction: effects on uterine, umbilical and fetal middle cerebral artery pulsatility indices. Ultrasound Obstet Gynecol. 2016;48(1):61–5.CrossRefPubMed
16.
go back to reference Mohammadi E, Teymoordash SN, Norouzi AR, Norouzi F, Norouzi HR. Comparison of the effect of nifedipine alone and the combination of nifedipine and sildenafil in delaying preterm labor: a randomized clinical trial. J Fam Reprod Health. 2021;15(2):112. Mohammadi E, Teymoordash SN, Norouzi AR, Norouzi F, Norouzi HR. Comparison of the effect of nifedipine alone and the combination of nifedipine and sildenafil in delaying preterm labor: a randomized clinical trial. J Fam Reprod Health. 2021;15(2):112.
17.
go back to reference El- Sayed Y, Hamed R, Aboelwan Y, Abdel-Salam WA, Hamed BM. Comparative study between nifedipine alone versus nifedipine combined with sildenafil citrate for cases with threatened preterm labour. Zagazig Univ Med J. 2023;29(1.1):1–8. El- Sayed Y, Hamed R, Aboelwan Y, Abdel-Salam WA, Hamed BM. Comparative study between nifedipine alone versus nifedipine combined with sildenafil citrate for cases with threatened preterm labour. Zagazig Univ Med J. 2023;29(1.1):1–8.
18.
go back to reference Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6.CrossRefPubMedPubMedCentral Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6.CrossRefPubMedPubMedCentral
19.
go back to reference Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, Thomas J. Updated guidance for trusted systematic reviews: a new edition of the cochrane handbook for systematic reviews of interventions. Cochrane Database Syst Rev. 2019;10(10):ED000142.PubMed Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, Thomas J. Updated guidance for trusted systematic reviews: a new edition of the cochrane handbook for systematic reviews of interventions. Cochrane Database Syst Rev. 2019;10(10):ED000142.PubMed
20.
go back to reference Kim SY, Park JE, Lee YJ, Seo H-J, Sheen S-S, Hahn S, et al. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol. 2013;66(4):408–14.CrossRefPubMed Kim SY, Park JE, Lee YJ, Seo H-J, Sheen S-S, Hahn S, et al. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol. 2013;66(4):408–14.CrossRefPubMed
21.
go back to reference Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5(1):1–10.CrossRef Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5(1):1–10.CrossRef
22.
go back to reference Hassan A, Waseem H, AlDardeir N, Nasief H, Khadawardi K, Alwazzan AB, et al. A Comparison of Nifedipine Versus a Combination of Nifedipine and Sildenafil Citrate in the Management of Preterm Labour. Cureus. 2023;15(7):e42422.PubMedPubMedCentral Hassan A, Waseem H, AlDardeir N, Nasief H, Khadawardi K, Alwazzan AB, et al. A Comparison of Nifedipine Versus a Combination of Nifedipine and Sildenafil Citrate in the Management of Preterm Labour. Cureus. 2023;15(7):e42422.PubMedPubMedCentral
23.
go back to reference Nasrolahei S, Hoseini SA, Hosseini SA, Hosseini SNK, Hosseini SS, Lotfi PM. Effect of nifedipine with and without sildenafil citrate for the management of preterm labor in pregnant women: A randomized clinical trial. Int J Reprod Biomed. 2023;21(5):379.PubMedPubMedCentral Nasrolahei S, Hoseini SA, Hosseini SA, Hosseini SNK, Hosseini SS, Lotfi PM. Effect of nifedipine with and without sildenafil citrate for the management of preterm labor in pregnant women: A randomized clinical trial. Int J Reprod Biomed. 2023;21(5):379.PubMedPubMedCentral
24.
go back to reference Singh SHSS. Effect of oral nifedipine or combined with sildenafil citrate for management of threatened preterm labour randomized trial. Indian Journal of Obstetrics and Gynecology Research. 2023;10(3):313–9.CrossRef Singh SHSS. Effect of oral nifedipine or combined with sildenafil citrate for management of threatened preterm labour randomized trial. Indian Journal of Obstetrics and Gynecology Research. 2023;10(3):313–9.CrossRef
25.
go back to reference Qurat-ul-ain FS, Fariha, Akmal N, Malik KK, Rashid M. Comparison between sildenafil citrate & nifedipine with nifedipine alone for the treatment of threatened preterm Labour. Pak J Med Health Sci. 2020;14(2):433–6. Qurat-ul-ain FS, Fariha, Akmal N, Malik KK, Rashid M. Comparison between sildenafil citrate & nifedipine with nifedipine alone for the treatment of threatened preterm Labour. Pak J Med Health Sci. 2020;14(2):433–6.
26.
go back to reference Maher M, Sayyed T, El-Khadry S. Retracted: nifedipine alone or combined with sildenafil citrate for management of threatened preterm labour: a randomised trial. BJOG. 2019;126(6):729–35.CrossRefPubMed Maher M, Sayyed T, El-Khadry S. Retracted: nifedipine alone or combined with sildenafil citrate for management of threatened preterm labour: a randomised trial. BJOG. 2019;126(6):729–35.CrossRefPubMed
27.
go back to reference Flenady V, Reinebrant HE, Liley HG, Tambimuttu EG, Papatsonis DN. Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst Rev. 2014;6(6):CD004452. Flenady V, Reinebrant HE, Liley HG, Tambimuttu EG, Papatsonis DN. Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst Rev. 2014;6(6):CD004452.
28.
go back to reference Flenady V, Wojcieszek AM, Papatsonis DN, Stock OM, Murray L, Jardine LA, Carbonne B. Calcium channel blockers for inhibiting preterm labour and birth. Cochrane Database Syst Rev. 2014;5(6):CD002255. Flenady V, Wojcieszek AM, Papatsonis DN, Stock OM, Murray L, Jardine LA, Carbonne B. Calcium channel blockers for inhibiting preterm labour and birth. Cochrane Database Syst Rev. 2014;5(6):CD002255.
29.
go back to reference Neilson JP, West HM, Dowswell T. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev. 2014;5(2):CD004352. Neilson JP, West HM, Dowswell T. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev. 2014;5(2):CD004352.
30.
go back to reference Wilson A, Hodgetts-Morton VA, Marson EJ, Markland AD, Larkai E, Papadopoulou A, et al. Tocolytics for delaying preterm birth: a network meta-analysis (0924). Cochrane Database Syst Rev. 2022;8(8):CD014978.PubMed Wilson A, Hodgetts-Morton VA, Marson EJ, Markland AD, Larkai E, Papadopoulou A, et al. Tocolytics for delaying preterm birth: a network meta-analysis (0924). Cochrane Database Syst Rev. 2022;8(8):CD014978.PubMed
31.
go back to reference Organization WH. WHO recommendations on interventions to improve preterm birth outcomes. 2015. Organization WH. WHO recommendations on interventions to improve preterm birth outcomes. 2015.
32.
go back to reference Eichenwald EC, Stark AR. Management and outcomes of very low birth weight. N Engl J Med. 2008;358(16):1700–11.CrossRefPubMed Eichenwald EC, Stark AR. Management and outcomes of very low birth weight. N Engl J Med. 2008;358(16):1700–11.CrossRefPubMed
34.
go back to reference Lakshmanan A, Song AY, Belfort MB, Yieh L, Dukhovny D, Friedlich PS, Gong CL. The financial burden experienced by families of preterm infants after NICU discharge. J Perinatol. 2022;42(2):223–30.CrossRefPubMed Lakshmanan A, Song AY, Belfort MB, Yieh L, Dukhovny D, Friedlich PS, Gong CL. The financial burden experienced by families of preterm infants after NICU discharge. J Perinatol. 2022;42(2):223–30.CrossRefPubMed
36.
go back to reference Ali AA, Sayed AK, El Sherif L, Loutfi GO, Ahmed AMM, Mohamed HB, et al. Systematic review and meta-analysis of randomized controlled trials of atosiban versus nifedipine for inhibition of preterm labor. Int J Gynecol Obstet. 2019;145(2):139–48.CrossRef Ali AA, Sayed AK, El Sherif L, Loutfi GO, Ahmed AMM, Mohamed HB, et al. Systematic review and meta-analysis of randomized controlled trials of atosiban versus nifedipine for inhibition of preterm labor. Int J Gynecol Obstet. 2019;145(2):139–48.CrossRef
37.
go back to reference Hirata K, Nakahari A, Takeoka M, Watanabe M, Nishimura Y, Katayama Y, et al. Prophylactic sildenafil in preterm infants at risk of bronchopulmonary dysplasia: A systematic review and meta-analysis. Authorea Preprints. 2023. Hirata K, Nakahari A, Takeoka M, Watanabe M, Nishimura Y, Katayama Y, et al. Prophylactic sildenafil in preterm infants at risk of bronchopulmonary dysplasia: A systematic review and meta-analysis. Authorea Preprints. 2023.
38.
go back to reference Dunn L, Greer R, Flenady V, Kumar S. Sildenafil in pregnancy: a systematic review of maternal tolerance and obstetric and perinatal outcomes. Fetal Diagn Ther. 2017;41(2):81–8.CrossRefPubMed Dunn L, Greer R, Flenady V, Kumar S. Sildenafil in pregnancy: a systematic review of maternal tolerance and obstetric and perinatal outcomes. Fetal Diagn Ther. 2017;41(2):81–8.CrossRefPubMed
39.
go back to reference Ferreira RDdS, Negrini R, Bernardo WM, Simoes R, Piato S. The effects of sildenafil in maternal and fetal outcomes in pregnancy: a systematic review and meta-analysis. PloS one. 2019;14(7):732.CrossRef Ferreira RDdS, Negrini R, Bernardo WM, Simoes R, Piato S. The effects of sildenafil in maternal and fetal outcomes in pregnancy: a systematic review and meta-analysis. PloS one. 2019;14(7):732.CrossRef
40.
go back to reference Pels A, Derks J, Elvan-Taspinar A, van Drongelen J, de Boer M, Duvekot H, et al. Maternal sildenafil vs placebo in pregnant women with severe early-onset fetal growth restriction: a randomized clinical trial. JAMA Netw Open. 2020;3(6):e205323.CrossRefPubMedPubMedCentral Pels A, Derks J, Elvan-Taspinar A, van Drongelen J, de Boer M, Duvekot H, et al. Maternal sildenafil vs placebo in pregnant women with severe early-onset fetal growth restriction: a randomized clinical trial. JAMA Netw Open. 2020;3(6):e205323.CrossRefPubMedPubMedCentral
Metadata
Title
Efficient administration of a combination of nifedipine and sildenafil citrate versus only nifedipine on clinical outcomes in women with threatened preterm labor: a systematic review and meta-analysis
Authors
Elham Manouchehri
Somayeh Makvandi
Mahdieh Razi
Maryam Sahebari
Mona Larki
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2024
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-024-04588-3

Other articles of this Issue 1/2024

BMC Pediatrics 1/2024 Go to the issue